发明名称 |
Use of MVA to treat prostate cancer |
摘要 |
The invention relates to compositions, kits, and methods for cancer prophylaxis and therapy using recombinant MVA viruses encoding tumor-associated antigens, such as PSA and PAP. The recombinant MVA viruses can induce B- and T-cell responses. The recombinant MVA viruses can be administered prior to, at the same time as, or after a taxane. |
申请公布号 |
AU2008312444(B2) |
申请公布日期 |
2014.02.06 |
申请号 |
AU20080312444 |
申请日期 |
2008.10.16 |
申请人 |
BAVARIAN NORDIC INC. |
发明人 |
DELCAYRE, ALAIN;ROUNTREE, RYAN BLAIR;LEGRAND, FATEMA;LAUS, REINER;MANDL, STEFANIE |
分类号 |
A61K39/00 |
主分类号 |
A61K39/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|